These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20192727)

  • 61. Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid.
    Shah M; Paradis S; Betz J; Beylis N; Bharadwaj R; Caceres T; Gotuzzo E; Joloba M; Mave V; Nakiyingi L; Nicol MP; Pradhan N; King B; Armstrong D; Knecht D; Maus CE; Cooper CK; Dorman SE; Manabe YC
    Clin Infect Dis; 2020 Aug; 71(5):1161-1167. PubMed ID: 31560049
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Programmatic Evaluation of an Algorithm for Intensified Tuberculosis Case Finding and Isoniazid Preventive Therapy for People Living With HIV in Thailand and Vietnam.
    Cowger TL; Thai LH; Duong BD; Danyuttapolchai J; Kittimunkong S; Nhung NV; Nhan DT; Monkongdee P; Thoa CK; Khanh VT; Nateniyom S; Yen NTB; Ngoc DV; Thinh T; Whitehead S; Pevzner ES
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):512-521. PubMed ID: 29023251
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluating the Auto-MODS assay, a novel tool for tuberculosis diagnosis for use in resource-limited settings.
    Wang L; Mohammad SH; Chaiyasirinroje B; Li Q; Rienthong S; Rienthong D; Nedsuwan S; Mahasirimongkol S; Yasui Y
    J Clin Microbiol; 2015 Jan; 53(1):172-8. PubMed ID: 25378569
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Improved recovery of Mycobacterium tuberculosis from children using the microscopic observation drug susceptibility method.
    Oberhelman RA; Soto-Castellares G; Caviedes L; Castillo ME; Kissinger P; Moore DA; Evans C; Gilman RH
    Pediatrics; 2006 Jul; 118(1):e100-6. PubMed ID: 16751616
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Implementation and Operational Research: Implementation of the WHO 2011 Recommendations for Isoniazid Preventive Therapy (IPT) in Children Living With HIV/AIDS: A Ugandan Experience.
    Costenaro P; Massavon W; Lundin R; Nabachwa SM; Fregonese F; Morelli E; Alowo A; Nannyonga Musoke M; Namisi CP; Kizito S; Bilardi D; Mazza A; Cotton MF; Giaquinto C; Penazzato M
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):e1-8. PubMed ID: 26761275
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
    Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A toolbox for tuberculosis diagnosis: an Indian multicentric study (2006-2008): microbiological results.
    Lagrange PH; Thangaraj SK; Dayal R; Despande A; Ganguly NK; Girardi E; Joshi B; Katoch K; Katoch VM; Kumar M; Lakshmi V; Leportier M; Longuet C; Malladi SV; Mukerjee D; Nair D; Raja A; Raman B; Rodrigues C; Sharma P; Singh A; Singh S; Sodha A; Kabeer BS; Vernet G; Goletti D
    PLoS One; 2012; 7(8):e43739. PubMed ID: 22937088
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa.
    Day JH; Charalambous S; Fielding KL; Hayes RJ; Churchyard GJ; Grant AD
    Int J Tuberc Lung Dis; 2006 May; 10(5):523-9. PubMed ID: 16704034
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria.
    E Ahiarakwem II; Ekejindu IM; Akujobi CN; Aghanya IN
    Niger J Clin Pract; 2020 Aug; 23(8):1172-1177. PubMed ID: 32788498
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
    Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
    Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Detection of multidrug-resistant tuberculosis using MGIT™(TM) and MAS-PCR in Tripura, India.
    Majumdar T; Bhattacharya S; Barman D; Bhoumik P; Bir R
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):166-9. PubMed ID: 26792467
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Morphological characterization of Mycobacterium tuberculosis in a MODS culture for an automatic diagnostics through pattern recognition.
    Alva A; Aquino F; Gilman RH; Olivares C; Requena D; Gutiérrez AH; Caviedes L; Coronel J; Larson S; Sheen P; Moore DA; Zimic M
    PLoS One; 2013; 8(12):e82809. PubMed ID: 24358227
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials.
    Ayele HT; Mourik MS; Debray TP; Bonten MJ
    PLoS One; 2015; 10(11):e0142290. PubMed ID: 26551023
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.
    Hermans SM; Grant AD; Chihota V; Lewis JJ; Vynnycky E; Churchyard GJ; Fielding KL
    BMC Med; 2016 Mar; 14():45. PubMed ID: 27004413
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The spectrum of primary drug resistance of Mycobacterium tuberculosis in patients with tuberculosis in relation to human immunodeficiency virus status].
    Zimina VN; Mikova OE; Varetskaya TA; Oborin DA; Degtyareva SY; Sergevnin VI
    Ter Arkh; 2017; 89(11):50-54. PubMed ID: 29260746
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting.
    Moore DA; Caviedes L; Gilman RH; Coronel J; Arenas F; LaChira D; Salazar C; Carlos Saravia J; Oberhelman RA; Hollm-Delgado MG; Escombe AR; Evans CA; Friedland JS
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):35-43. PubMed ID: 16678991
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis.
    Dixit P; Singh U; Sharma P; Jain A
    J Microbiol Methods; 2012 Jan; 88(1):122-6. PubMed ID: 22133919
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.